(Adnkronos) - 350 esperti nazionali e internazionali riuniti a Torino per il quarto Congresso Nazionale della SI-GUIDA, la Società Italiana per la Gestione Unificata e Interdisciplinare del Dolore Muscolo-Scheletrico e dell’Algodistrofia. “Un’occasione per trattare molti temi legati al dolore cronico – afferma il Prof. Giovanni Iolascon, Ortopedico e Fisiatra e Presidente della SI-GUIDA – con un focus particolare sull’algodistrofia, una malattia ritenuta rara ma che in realtà non lo è, e della quale abbiamo a disposizione nuovi dati per migliorare il trattamento farmacologico”.
Category
🗞
NewsTranscript
00:00 The fourth Guida Congress, which is held in Turin these days,
00:04 is a congress that, as usual,
00:07 focuses on the participation of the three specialists
00:11 who deal with skeletal muscle pain,
00:14 that is, orthopedics, physiotherapists and rheumatologists.
00:17 Within the congress sessions,
00:20 many of the themes of chronic pain will be addressed,
00:23 in particular those regarding fibromyalgia,
00:27 which is an emerging pathology
00:28 that always affects a larger number of Italian women.
00:32 Lumbalgia is a very common pathology,
00:36 but we still know little about it,
00:38 and in particular we will still deal with algodystrophy.
00:42 This is a rare disease,
00:44 but it is not actually rare.
00:46 And we will present new data on this pathology
00:49 regarding the pharmacological treatment,
00:51 in particular new methods of administration of a drug
00:56 that is already prescribed in the national health system,
01:00 the neroidronato.